Network·Hedge Fund
📍 ST. HELIER
SEC CRD #802-123196
Welcome | B-FLEXION Skip to main content Home About History People Investing Responsibility News Contact Contact B-FLEXION is a private, entrepreneurial investment firm, partnering with sophisticated capital to meet the shared goal of delivering exceptional value over the generations, while also contributing positively to society. B-FLEXION has offices across Europe and in the United States. About B-FLEXION CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing Wed, 04/29/2026 - 16:47 Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform Wed, 03/18/2026 - 15:28 Paratek Pharmaceuticals Announces Positive Results for NUZYRA® Therapeutic Efficacy Studies in Inhalation Anthrax Triggering Additional Procurement under BARDA Project BioShield Contract Tue, 02/24/2026 - 15:13 Read more History History From a biopharmaceutical company grown over the course of three generations, to an investment track-record built over 20 years, we are proud of our heritage. Learn more People People Targeting and developing the best talent is B-FLEXION's most important strategic imperative, with its people's commitment to the group's values central to everything that it does. Learn more Businesses With the first of its businesses, Kedge Capital, established 20 years ago, the B-FLEXION group has now grown to encompass successful asset managers across a variety of investment areas, as
MICHAL CHMIELEWSKI
HEAD OF RISK & COMPLIANCE, JERSEY
📞 +44 1534 753500
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Location
ST. HELIER
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.